Navigation Links
Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products based on the extracellular matrix, today announced that Jonathan Lim, MD, Halozyme's President and Chief Executive Officer, will present at the UBS 2007 Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York on Monday, September 24, 2007 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time).

Interested parties can access a live audio webcast and accompanying slide presentation via the Internet by visiting the Investor Relations section of the Company's Web site at http://www.halozyme.com. Archived presentations will be available on the Web site for 30 days following the presentation.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products based on the extracellular matrix for the drug delivery, oncology, and dermatology markets. The company's portfolio of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its first partnership is with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets. In addition, the company has received FDA approval for two products: Cumulase(R) and HYLENEX, for use as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids. HYLENEX is partnered with Baxter Healthcare Corporation. The Company also has a number of different enzymes
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...FirstCall/ -- NeoStem, Inc.,(NYSE Alternext US: N...n,processing and long-term storage of adult stem...hat it has reached a major milestone in its curren...r collection center for collection of,adult stem ...d in New York,City and has chosen Bruce Yaffe, M....
(Date:12/4/2008)...e/ -- Azur Pharma Limited ("Azur") today,announce...with BioSante,Pharmaceuticals, Inc ("BioSante")(N...n(TM). Elestrin is a fast drying gel formulation o...of moderate to severe vasomotor symptoms,associat...S. Food and Drug,Administration ("FDA") in Decemb...
(Date:12/4/2008)...ire/ -- Parion Sciences, Inc. today announced,tha...has initiated a Phase I,clinical trial of GS9411 ...tolerability of the investigational compound. GS9...the treatment of pulmonary disease. Previously kn...nel (ENaC) blocker discovered by,Parion, a privat...
(Date:12/4/2008)...sted LASIK Surgeons launched its revolutionary Tru...at www.TrustedLASIKSurgeons.com in order to prov...eir vision. What sets the Trusted LASIK Surgeons d...ing that only those who are among the best in LASI...States are listed. Refractive eye surgeons, such ...
Breaking Biology Technology:NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 2Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 4Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 5Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 6Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 7
...oCycler 40 Temperature Cycler allows rapid,ampli...* Robert E. Carroll * Richard V. Benya ,Departme..., , , , , Figure 1: R...apter System, In situ adapter system for t...igned for holding standard microscope slides., ...
..., Culture 192 clones simultaneously with the tem...e , , , Figure 1: The tempest T...thermoshaker and a 96-deep-well, round-bott...n a, high-throughput format. Early- and mid...equivalent in aerated and nonaerated wells of the ...
... complete control system for inducible mammalia...lancourt ,Stratagene , The complete control ...,control of gene expression in a wide range of ma...in the system is naturally repressed in the absenc...n a double-stable cell line, a linear,dose-respo...
..., ,Economical quantitative PCR (QPCR) reagent...es , Gothami Padmabandu Lisa Grismer Reinh...t quantitative PCR and RT-PCR core,reagent kits ...,technologies. Several versions have been created ...(UNG) decontamination control reagents. All kits i...
Other Biology Technology:Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived,Tissue 2Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived,Tissue 3Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived,Tissue 4Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived,Tissue 5Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived,Tissue 6High-Throughput Cultivation of Bacterial Clones 2High-Throughput Cultivation of Bacterial Clones 3Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 2Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 3Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 4Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 5Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 6Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 7Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 8Brilliant Core Reagent Kits for QPCR and QRT-PCR 2Brilliant Core Reagent Kits for QPCR and QRT-PCR 3Brilliant Core Reagent Kits for QPCR and QRT-PCR 4Brilliant Core Reagent Kits for QPCR and QRT-PCR 5Brilliant Core Reagent Kits for QPCR and QRT-PCR 6Brilliant Core Reagent Kits for QPCR and QRT-PCR 7Brilliant Core Reagent Kits for QPCR and QRT-PCR 8Brilliant Core Reagent Kits for QPCR and QRT-PCR 9Brilliant Core Reagent Kits for QPCR and QRT-PCR 10Brilliant Core Reagent Kits for QPCR and QRT-PCR 11Brilliant Core Reagent Kits for QPCR and QRT-PCR 12Brilliant Core Reagent Kits for QPCR and QRT-PCR 13Brilliant Core Reagent Kits for QPCR and QRT-PCR 14
(Date:12/3/2008)...us to insert a corrective gene into mouse blood ce...spital have alleviated sickle cell disease patholo...he treated mice showed essentially no difference f...hat applying the gene therapy to humans presents s...the new therapy will become an important treatment...
(Date:12/3/2008)...ding success of the first tandem mission between E... satellites together again to help improve our und... spacecraft, and Envisat, the largest environmenta...ure Radar (SAR) instruments that provide high reso...ning two or more SAR images of the same site, slig...
(Date:12/3/2008)...E, Mass. Natural changes in voltage that occur ac...powerful controlling factor in the process by whic...earch published by Tufts University scientists. ,...ssor of Biology Michael Levin, and Chair of Biomed...thor) published their paper "Membrane Potential C...
(Date:12/2/2008)...body may come with some substantial benefits for s...ber issue of Current Anthropology . , The horm...petitive and better able to deal with stress also ...t, according to Elizabeth Cashdan, an anthropologi...situations where women are under pressure to procu...
Breaking Biology News(10 mins):Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA satellites flying in formation 2New 'control knobs' for stem cells identified 2Why the 'perfect' body isn't always perfect 2Long Term Followup in Phase 3 CLL Trial Shows Genasense 28R 29 is Associated with Significantly Increased Survival in All Responders 2221 1Long Term Followup in Phase 3 CLL Trial Shows Genasense 28R 29 is Associated with Significantly Increased Survival in All Responders 2221 2Long Term Followup in Phase 3 CLL Trial Shows Genasense 28R 29 is Associated with Significantly Increased Survival in All Responders 2221 3Long Term Followup in Phase 3 CLL Trial Shows Genasense 28R 29 is Associated with Significantly Increased Survival in All Responders 2221 4InterMune Announces Start of 14 Day Triple Combination Study of ITMN 191 in Patients With Chronic Hepatitis C 2219 1InterMune Announces Start of 14 Day Triple Combination Study of ITMN 191 in Patients With Chronic Hepatitis C 2219 2InterMune Announces Start of 14 Day Triple Combination Study of ITMN 191 in Patients With Chronic Hepatitis C 2219 3InterMune Announces Start of 14 Day Triple Combination Study of ITMN 191 in Patients With Chronic Hepatitis C 2219 4Wyeth Receives FDA Fast Track Designation for its 13 valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2217 1Wyeth Receives FDA Fast Track Designation for its 13 valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2217 2Wyeth Receives FDA Fast Track Designation for its 13 valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2217 3Wyeth Receives FDA Fast Track Designation for its 13 valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2217 4Type of Tomato Product Determines Power Against Prostate Cancer 20497 1Type of Tomato Product Determines Power Against Prostate Cancer 20497 2Type of Tomato Product Determines Power Against Prostate Cancer 20497 3
x
... nerve damage caused by diabetes could bring relie..., The treatment might also reduce the number of am...ve protection and regeneration are borne out long-... of non-traumatic lower limb amputations in Europe... of Manchester, working with colleagues at America...
...earchers discover that animals zig when they were ..., In studying the spatial memory of wild-caught mo...rs were surprised to discover the birds contradict...e. This study is the first to reveal a different p...sed in human-made enclosures had been tested. , Th...
...model, a correlation-based statistical method is a...s and pinpoint genes that may be potential cancer ...ty research. , The research is important because ...n gene connections, a task critical for understand...s appeared this week in the online edition of the ...
Other Biology News:Diabetic nerve therapy shows 'striking' results 2Chickadees can help humans get their bearings 2Researchers develop promising new gene network analysis method 2
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry.
II Plate Washer (Classic) from GE Healthcare, formerly Amersham Biosciences
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry.
Antibodies were affinity purified using epitopes specific to PPP1CC immobilized on solid support.
Biology Products: